521
Views
13
CrossRef citations to date
0
Altmetric
Research Articles

Evaluation of acute and subacute toxicity of sodium taurodeoxycholate in rats

, , , , , , , , & show all
Pages 268-276 | Received 11 Feb 2018, Accepted 22 Jan 2019, Published online: 19 Jun 2019

References

  • Aubert, E., et al., 2002. Site-directed mutagenesis of the basic N-terminal cluster of pancreatic bile salt-dependent lipase functional significance. Journal of Biological Chemistry, 277(38), 34987–34996.
  • Bhatt, D.L., et al., 2006. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. The New England Journal of Medicine, 354(16), 1706–1717.
  • Boyer, J.L., 2013. Bile formation and secretion. Comprehensive Physiology, 3(3), 1035–1078.
  • Campbell, C.L., et al., 2007. Aspirin dose for the prevention of cardiovascular disease: a systematic review. JAMA, 297(18), 2018–2024.
  • Chen, C.F., and Kuo, C.H., 1992. Toxic effect of bile acid ingestion in rats. Journal of the Formosan Medical Association, 91(8), 743–746.
  • Chen, X., et al., 2011. TGR5: a novel target for weight maintenance and glucose metabolism. Experimental Diabetes Research, 2011, 853501.
  • Copple, B.L., and Li, T., 2016. Pharmacology of bile acid receptors: evolution of bile acids from simple detergents to complex signaling molecules. Pharmacological Research, 104, 9–21.
  • De Bernardi di Valserra, M., et al., 1993. Chronic toxicity of taurohyodeoxycholic acid in rats. Arzneimittel-Forschung, 43(8), 880–887.
  • de Jong, H.K., van der Poll, T., and Wiersinga, W.J., 2010. The systemic pro-inflammatory response in sepsis. Journal of Innate Immunity, 2(5), 422–430.
  • Diehl, K., et al., 2001. European Federation of Pharmaceutical Industries Association and European Centre for the Validation of Alternative Methods 2001. A good practice guide to the administration of substances and removal of blood, including routes and volumes. Journal of Applied Toxicology, 21(1), 15–23.
  • Doi, K., et al., 2009. Animal models of sepsis and sepsis-induced kidney injury. The Journal of Clinical Investigation, 119(10), 2868–2878.
  • Dopico, A.M., Walsh, J.V., Jr., and Singer, J.J., 2002. Natural bile acids and synthetic analogues modulate large conductance Ca2+-activated K+ (BKCa) channel activity in smooth muscle cells. The Journal of General Physiology, 119(3), 251–273.
  • Feletti, F., et al., 1993. Chronic toxicity of taurohyodeoxycholic acid in dogs. Arzneimittel-Forschung, 43(8), 888–893.
  • Ferrari, C., et al., 2006. Pharmacophore model for bile acids recognition by the FPR receptor. Journal of Computer-Aided Molecular Design, 20(5), 295–303.
  • Greve, J.W., Gouma, D.J., and Buurman, W.A., 1989. Bile acids inhibit endotoxin-induced release of tumor necrosis factor by monocytes: an in vitro study. Hepatology, 10(4), 454–458.
  • Guo, C., et al., 2015. The G-protein-coupled bile acid receptor Gpbar1 (TGR5) inhibits gastric inflammation through antagonizing NF-kappaB signaling pathway. Frontiers in Pharmacology, 6, 287.
  • Guo, C., et al., 2016. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity, 45(4), 944.
  • Han, S.C., et al., 2010. Toxicity study of a new camptothecin anti-cancer agent CKD-602 in dogs: 4-week continuous intravenous dose by infusion pump and 4-week repeated intravenous dose. Regulatory Toxicology and Pharmacology, 58(2), 275–284.
  • KFDA, 2014. Good laboratory practice regulation for non-clinical laboratory studies (Notification No. 2012-61). Korea: KFDA. Available from http://nifds.go.kr/cyber/GLP/GLP2014/index.html [October 2014].
  • Kishimoto, S., et al., 1986. Experimental model of gastritis induced by sodium taurocholate in rats. Hiroshima Journal of Medical Sciences, 35(2), 143–147.
  • Lai, Y., et al., 1996. Toxicity of bile salts (sodium cholate and sodium chenodeoxycholate) in rats. Nutrition Science Journal, 21, 288–297.
  • McMillin, M., et al., 2015. TGR5 signaling reduces neuroinflammation during hepatic encephalopathy. Journal of Neurochemistry, 135(3), 565–576.
  • OECD, 2001. OECD guideline for testing of chemicals, Test No. 420: Acute Oral Toxicity – Fixed Dose Procedure.
  • OECD, 2008. OECD guideline for testing of chemicals, Test No. 407: Repeated Dose 28-Day Oral Toxicity Study in Rodents.
  • Palmer, R.H., 1972. Bile acids, liver injury, and liver disease. Archives of Internal Medicine, 130(4), 606–617.
  • Panicot-Dubois, L., et al., 2007. Bile salt–dependent lipase interacts with platelet CXCR4 and modulates thrombus formation in mice and humans. Journal of Clinical Investigation, 117(12), 3708–3719.
  • Prichard, P.J., et al., 1989. Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin. BMJ (Clinical Research ed.), 298(6672), 493–496.
  • Raufman, J.P., et al., 2002. Selective interaction of bile acids with muscarinic receptors: a case of molecular mimicry. European Journal of Pharmacology, 457(2–3), 77–84.
  • Reagan-Shaw, S., et al., 2008. Dose translation from animal to human studies revisited. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 22(3), 659–661.
  • Riepl, R.L., et al., 1990. Effect of intraduodenal bile and Na-taurodeoxycholate on exocrine pancreatic secretion and on plasma levels of secretin, pancreatic polypeptide, and gastrin in man. Scandinavian Journal of Gastroenterology, 25(1), 45–53.
  • Rutishauser, S.C., and Stone, S.L., 1975. Comparative effects of sodium taurodeoxycholate and sodium taurocholate on bile secretion in the rat, dog and rabbit. The Journal of Physiology, 245(3), 583–598.
  • Sayin, S.I., et al., 2013. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metabolism, 17(2), 225–235.
  • Schaap, F.G., Trauner, M., and Jansen, P.L., 2014. Bile acid receptors as targets for drug development. Nature Reviews. Gastroenterology & Hepatology, 11(1), 55–67.
  • Wang, J.-M., et al., 2005. Hepatic injury in rats with obstructive jaundice: roles of the protein kinase C signal pathway and cytoprotection of fructose. Hepatobiliary & Pancreatic Diseases International, 4(4), 577–581.
  • Watanabe, M., et al., 2006. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature, 439(7075), 484–489.
  • Wong, F., et al., 2005. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut, 54(5), 718–725.
  • Yeh, Y.H., et al., 2003. Bile acid composition in snake bile juice and toxicity of snake bile acids to rats. Comparative Biochemistry and Physiology. Toxicology & Pharmacology: CBP, 136(3), 277–284.
  • Yeomans, N.D., et al., 2009. Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-inflammatory drugs. Current Medical Research and Opinion, 25(11), 2785–2793.
  • Yun, J.W., et al., 2017. Preclinical safety assessment of Angelica acutiloba using a 13-week repeated dose oral toxicity study in rats. Laboratory Animal Research, 33(3), 223–230.
  • Zhou, H., and Hylemon, P.B., 2014. Bile acids are nutrient signaling hormones. Steroids, 86, 62–68.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.